Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,710 | 100 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $336.23 | 15 | $0 (2024) |
| Lilly USA, LLC | $228.30 | 16 | $0 (2024) |
| ABBVIE INC. | $224.57 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $130.90 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $107.23 | 6 | $0 (2024) |
| PFIZER INC. | $98.15 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $82.03 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $76.41 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $70.24 | 4 | $0 (2024) |
| SANOFI PASTEUR INC. | $68.31 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,344 | 81 | Novo Nordisk Inc ($280.39) |
| 2023 | $308.60 | 18 | Lilly USA, LLC ($79.66) |
| 2022 | $56.90 | 1 | Organon LLC ($56.90) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: VACCINES | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | SANOFI PASTEUR INC. | VAXELIS (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Vaccines | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Biological | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.64 | General |
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.52 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.08 | General |
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Biological | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 167 | 192 | $32,326 | $10,412 |
| 2022 | 6 | 302 | 360 | $48,755 | $19,121 |
| 2021 | 4 | 140 | 143 | $12,866 | $6,882 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 62 | $12,198 | $3,837 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 76 | $9,821 | $3,186 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 19 | $4,995 | $2,080 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,092 | $1,185 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 18 | $220.00 | $123.20 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 184 | $22,448 | $9,104 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 104 | $18,928 | $7,234 | 38.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $5,600 | $2,519 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $1,065 | $129.52 | 12.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 28 | $504.00 | $83.22 | 16.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 15 | $210.00 | $51.49 | 24.5% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 64 | 64 | $2,688 | $2,406 | 89.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 31 | $5,642 | $2,341 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 33 | $4,026 | $1,896 | 47.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $510.00 | $240.45 | 47.1% |
About Daniel Peralta
Daniel Peralta is a Physician Assistant healthcare provider based in Taos, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2021. The National Provider Identifier (NPI) number assigned to this provider is 1952990079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Peralta has received a total of $1,710 in payments from pharmaceutical and medical device companies, with $1,344 received in 2024. These payments were reported across 100 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,710).
As a Medicare-enrolled provider, Peralta has provided services to 609 Medicare beneficiaries, totaling 695 services with total Medicare billing of $36,415. Data is available for 3 years (2021–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Taos, NM
- Active Since 01/13/2021
- Last Updated 01/13/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1952990079
Products in Payments
- JARDIANCE (Drug) $154.95
- Wegovy (Drug) $151.54
- REXULTI (Drug) $129.19
- QULIPTA (Drug) $122.83
- MOUNJARO (Drug) $119.78
- Ozempic (Drug) $90.67
- PAXLOVID (Drug) $81.78
- Veozah (Drug) $76.41
- NEXPLANON (Drug) $56.90
- FARXIGA (Drug) $56.01
- UBRELVY (Drug) $55.38
- VOQUEZNA (Drug) $50.06
- SHINGRIX (Biological) $48.10
- VRAYLAR (Drug) $46.36
- Cologuard Collection Kit (Device) $35.84
- VAXELIS (Biological) $34.75
- MENQUADFI (Biological) $33.56
- BREZTRI (Drug) $30.63
- TRELEGY ELLIPTA (Drug) $22.14
- GVOKE HYPOPEN (Drug) $22.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Taos
Brittney Coe, Pa-C, PA-C
Physician Assistant — Payments: $211.91
Christa Castro, Pa, PA
Physician Assistant — Payments: $184.60
Charlton Weyer, Pa-C, PA-C
Physician Assistant — Payments: $154.41
Mr. Abraham Balsamo, P.a.-C, P.A.-C
Physician Assistant — Payments: $138.87
Gina Torres Balsamo, Pa-C, PA-C
Physician Assistant — Payments: $138.87
Ms. Elizabeth Martinez, P.a.-C, P.A.-C
Physician Assistant — Payments: $126.87